In commemoration of the European pioneer in cancer research and treatment, founding member and first President of ESMO, Prof. Georges Mathé, the ESMO Award in Immuno-Oncology is presented to an individual internationally recognised for outstanding achievements in the area of Immuno-Oncology.
The recipient will be nominated by the ESMO Immuno-Oncology Congress Scientific Committee.
The award consists of the opportunity to give a scientific lecture, a prize and free registration, free accommodation and reimbursement of travel expenses to ESMO Immuno-Oncology Congress in Geneva, Switzerland.
Nomination and selection process
Each member of the ESMO Immuno-Oncology Scientific Committee may nominate a candidate who meets the eligibility criteria below:
- Be an individual (institutions and organisations are not eligible) who has made a significant impact in the field of immuno-oncology.
- Be an oncology professional, medical or clinical oncologist or researcher
- Be an ESMO member
- Not be a current or recent (last two years) member of either the ESMO Executive Board, the ESMO Council or the ESMO Nomination Committee
- Not be a member of the current ESMO Immuno-Oncology Congress Scientific Committee
All nominations will be evaluated, and a final awardee will be selected by the Selection Committee: ESMO Nomination Committee Chair, Scientific Co-Chairs of the ESMO Immuno-Oncology Congress. This recommendation is forwarded to the ESMO Executive Board for final approval.
Georges Mathé was previously commemorated via the Georges Mathé Translational Research Fellowship (2012-2016). As of 2017, the fellowship has been replaced by the ESMO Award for Immuno-Oncology.